Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Gruel

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Journal Des Maladies Vasculaires|January 1, 1986
[Preliminary study of the use of low-molecular weight heparin to prevent thrombotic risk]B Delahousse, Y Gruel, P Moalic, et al.
Annales De Pediatrie|February 1, 1986
[Extensive colonic necrosis indicative of a hemolytic and uremic syndrome]L Guibert, H Jouan, B Fremond, et al.
Thrombosis and Haemostasis|January 1, 1995
Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in cultureP Reverdiau, A C Jarousseau, G Thibault, et al.
The Journal of Laboratory and Clinical Medicine|December 16, 1998
Human allogeneic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathwayP Reverdiau-Moalic, H Watier, S Iochmann, et al.
Annals of Vascular Surgery|November 1, 1991
Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosisY Gruel, P Lermusiaux, M Lang, et al.
Transplantation Proceedings|June 1, 1994
Human peripheral blood lymphocyte adhesion to xenogeneic porcine aortic endothelial cells: preferential adhesion of CD3-CD16+ NK cellsB Birmelé, G Thibault, H Watier, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's diseaseL Macchi, R Sarfati, M Guicheteau, et al.
British Journal of Cancer|February 3, 2005
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancerJ Rollin, S Iochmann, C Bléchet, et al.
Thrombosis Research|June 1, 1991
Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assayY Gruel, A Rupin, L Darnige, et al.
Chirurgie Pediatrique|January 1, 1987
[Tumors of the liver secondary to androgen therapy. Apropos of 2 cases in children]B Frémond, H Jouan, A H Sameh, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Journal Des Maladies Vasculaires|January 1, 1986
[Preliminary study of the use of low-molecular weight heparin to prevent thrombotic risk]B Delahousse, Y Gruel, P Moalic, et al.
Annales De Pediatrie|February 1, 1986
[Extensive colonic necrosis indicative of a hemolytic and uremic syndrome]L Guibert, H Jouan, B Fremond, et al.
Thrombosis and Haemostasis|January 1, 1995
Tissue factor activity of syncytiotrophoblast plasma membranes and tumoral trophoblast cells in cultureP Reverdiau, A C Jarousseau, G Thibault, et al.
The Journal of Laboratory and Clinical Medicine|December 16, 1998
Human allogeneic lymphocytes trigger endothelial cell tissue factor expression by a tumor necrosis factor-dependent pathwayP Reverdiau-Moalic, H Watier, S Iochmann, et al.
Annals of Vascular Surgery|November 1, 1991
Usefulness of antiplatelet drugs in the management of heparin-associated thrombocytopenia and thrombosisY Gruel, P Lermusiaux, M Lang, et al.
Transplantation Proceedings|June 1, 1994
Human peripheral blood lymphocyte adhesion to xenogeneic porcine aortic endothelial cells: preferential adhesion of CD3-CD16+ NK cellsB Birmelé, G Thibault, H Watier, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 13, 2000
Thromboembolic prophylaxis with danaparoïd (Orgaran) in a high-thrombosis-risk pregnant woman with a history of heparin-induced thrombocytopenia (HIT) and Widal's diseaseL Macchi, R Sarfati, M Guicheteau, et al.
British Journal of Cancer|February 3, 2005
Expression and methylation status of tissue factor pathway inhibitor-2 gene in non-small-cell lung cancerJ Rollin, S Iochmann, C Bléchet, et al.
Thrombosis Research|June 1, 1991
Specific quantification of heparin-dependent antibodies for the diagnosis of heparin-associated thrombocytopenia using an enzyme-linked immunosorbent assayY Gruel, A Rupin, L Darnige, et al.
Chirurgie Pediatrique|January 1, 1987
[Tumors of the liver secondary to androgen therapy. Apropos of 2 cases in children]B Frémond, H Jouan, A H Sameh, et al.
Pageof 14